Angios Biotech is an Austrian biotechnology company specializing in cell-based research focused on vascular diseases, utilizing induced pluripotent stem cells (iPSC) to develop novel therapies.

Angios Biotech

Genesignal provides diagnostic services focusing on the detection of various medical conditions through advanced testing methodologies. self-described.

Genesignal

Angios FlexCo | 649 followers on LinkedIn. Novel approaches to vascular therapy | Angios is a biotechnology company, specializing in vascular research to improve patients&#39; lives all over the world. We are based in the beautiful city of Innsbruck. We strive to develop new treatments for challenging diabetic vascular diseases by pursuing pre-identified targets for diabetic retinopathy and by leveraging the vascular organoid model developed in the laboratories of our founders.

Senior Scientist

Azarakhsh Oladzad

Scientist & Lab Manager @ Angios GmbH | Ph.D. in Pharmaceutical Sciences & B.A. (MCI) in Business Administration | Digital Marketing enthusiast

Tanila Ben Haddou

Biotechnologin

Nicole Przysiecki

CEO & Founder bei Angios Flexco, Consultant to Life Sciences companies/investors

Gregor Wick

Angios FlexCo

Danke an alle, die uns bei der Langen Nacht der Forschung am 24.05 im CCB Innsbruck besucht haben! Wir sind begeistert, wie viele junge WissenschaftlerInnen sich für Organoidforschung interessieren.

Hands on with Angios at the Lange Nacht der Forschung!

Join us on Friday 24.05.2024 at the CCB Innsbruck for an exciting night of research.

Angios with partners from SWEEPICS consortium in our kick-off meeting in Lübeck. Check us out at www.sweepics.eu

Angios at the PhD Life science meeting in Innsbruck.

We are hiring! Check out the position on our website www.angios-bio.com

Metric
Company Name	Angios Biotech	Genesignal
Symbol
MSH ID	COM:ANGIOS-BIO	COM:GENESIGNAL
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Biotechnology	Healthcare
Country	AT	GB
Stage		Seed
Employee Count
Website	angios-bio.com	genesignal.com
LinkedIn	angios-gmbh	gene-signal
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	201	1.52K
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

ANGI

COM:ANGIOS-BIO

Angios Biotech

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue